Tag
Drugmaker Merck on Tuesday (Jul 29) announced job and cost cuts it said will save US$3 billion a year as it posted lower second-quarter results due to continuing weak demand for its…
Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing deals to offset the upcoming patent expiry of its blockbuster cancer drug,…
K has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times reported on Monday, citing three people familiar with the…
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million upfront, plus as much as US$2.7 billion in milestone payments. The…
GERMAN science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for US$600 million, it said ahead of its…
